Pevonedistat in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis

NCT03386214 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Sponsor stopped development of pevonedistat

Conditions

Myelofibroses

Interventions

DRUG: Pevonedistat
DRUG: Ruxolitinib
PROCEDURE: Peripheral blood draw
PROCEDURE: Skin biopsy

Sponsor

Washington University School of Medicine

Collaborators

[object Object]